Elon's Vision
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Stock

Dr. Jan Adams named Chief Commercial Officer at Grünenthal

by
September 30, 2024
in Stock
0
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Aachen, Germany – Global pharmaceutical company Grünenthal announced today that Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will be taking on the role of Chief Commercial Officer (CCO) effective October 1st, 2024. Adams has over two decades of experience in the pharmaceutical and healthcare industry. Since joining Grünenthal in 2017…

Source

Previous Post

Celebrate World Animal Day by Donating a Dinner to Local Rescue Centres, Charity Urges

Next Post

Homeownership Is Not the American Dream

Next Post

Homeownership Is Not the American Dream

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

Microsoft Planner vs Trello: Which Project Management Tool is Better?

May 24, 2023
Nicole Kidman Joins Paycom Webinar and Podcast to Talk Leadership, Tech and Work-Life Balance 

Nicole Kidman Joins Paycom Webinar and Podcast to Talk Leadership, Tech and Work-Life Balance 

January 31, 2025

An update on the National Nature Assessment

April 23, 2025
Youth unemployment hits 11-year high as rate cut expectations build

Youth unemployment hits 11-year high as rate cut expectations build

0

0

0

0
Youth unemployment hits 11-year high as rate cut expectations build

Youth unemployment hits 11-year high as rate cut expectations build

February 19, 2026
Nine in 10 high-risk pension funds fail to beat FTSE 100 over five years

Nine in 10 high-risk pension funds fail to beat FTSE 100 over five years

February 19, 2026
Getting To Know You: James Doyle, Managing Director of Endeavour Group

Getting To Know You: James Doyle, Managing Director of Endeavour Group

February 19, 2026
Small businesses warn of April ‘perfect storm’ as costs surge

Small businesses warn of April ‘perfect storm’ as costs surge

February 19, 2026

Recent News

Youth unemployment hits 11-year high as rate cut expectations build

Youth unemployment hits 11-year high as rate cut expectations build

February 19, 2026
Nine in 10 high-risk pension funds fail to beat FTSE 100 over five years

Nine in 10 high-risk pension funds fail to beat FTSE 100 over five years

February 19, 2026
Getting To Know You: James Doyle, Managing Director of Endeavour Group

Getting To Know You: James Doyle, Managing Director of Endeavour Group

February 19, 2026
Small businesses warn of April ‘perfect storm’ as costs surge

Small businesses warn of April ‘perfect storm’ as costs surge

February 19, 2026

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.